Tae Kwang Corporation

KOSDAQ:A023160 Stok Raporu

Piyasa değeri: ₩318.9b

Tae Kwang Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Tae Kwang has a total shareholder equity of ₩592.9B and total debt of ₩0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₩644.7B and ₩51.8B respectively. Tae Kwang's EBIT is ₩42.4B making its interest coverage ratio -5.4. It has cash and short-term investments of ₩118.3B.

Anahtar bilgiler

0%

Borç/özkaynak oranı

₩0

Borç

Faiz karşılama oranı-5.4x
Nakit₩118.32b
Eşitlik₩592.93b
Toplam yükümlülükler₩51.81b
Toplam varlıklar₩644.75b

Son finansal sağlık güncellemeleri

Recent updates

Investors Aren't Buying Tae Kwang Corporation's (KOSDAQ:023160) Earnings

Oct 25
Investors Aren't Buying Tae Kwang Corporation's (KOSDAQ:023160) Earnings

Tae Kwang Corporation's (KOSDAQ:023160) Intrinsic Value Is Potentially 80% Above Its Share Price

Sep 06
Tae Kwang Corporation's (KOSDAQ:023160) Intrinsic Value Is Potentially 80% Above Its Share Price

Should You Be Adding Tae Kwang (KOSDAQ:023160) To Your Watchlist Today?

Aug 05
Should You Be Adding Tae Kwang (KOSDAQ:023160) To Your Watchlist Today?

Tae Kwang Corporation (KOSDAQ:023160) Surges 33% Yet Its Low P/E Is No Reason For Excitement

Jul 17
Tae Kwang Corporation (KOSDAQ:023160) Surges 33% Yet Its Low P/E Is No Reason For Excitement

Tae Kwang (KOSDAQ:023160) Shareholders Will Want The ROCE Trajectory To Continue

Jul 16
Tae Kwang (KOSDAQ:023160) Shareholders Will Want The ROCE Trajectory To Continue

Does Tae Kwang (KOSDAQ:023160) Deserve A Spot On Your Watchlist?

Apr 24
Does Tae Kwang (KOSDAQ:023160) Deserve A Spot On Your Watchlist?

Additional Considerations Required While Assessing Tae Kwang's (KOSDAQ:023160) Strong Earnings

Mar 31
Additional Considerations Required While Assessing Tae Kwang's (KOSDAQ:023160) Strong Earnings

Investors Will Want Tae Kwang's (KOSDAQ:023160) Growth In ROCE To Persist

Mar 07
Investors Will Want Tae Kwang's (KOSDAQ:023160) Growth In ROCE To Persist

Tae Kwang (KOSDAQ:023160) Has Debt But No Earnings; Should You Worry?

May 05
Tae Kwang (KOSDAQ:023160) Has Debt But No Earnings; Should You Worry?

Is Tae Kwang Corporation (KOSDAQ:023160) A Good Fit For Your Dividend Portfolio?

Apr 08
Is Tae Kwang Corporation (KOSDAQ:023160) A Good Fit For Your Dividend Portfolio?

Is Tae Kwang (KOSDAQ:023160) Set To Make A Turnaround?

Mar 13
Is Tae Kwang (KOSDAQ:023160) Set To Make A Turnaround?

Tae Kwang's (KOSDAQ:023160) Stock Price Has Reduced 47% In The Past Three Years

Feb 15
Tae Kwang's (KOSDAQ:023160) Stock Price Has Reduced 47% In The Past Three Years

What Kind Of Shareholders Hold The Majority In Tae Kwang Corporation's (KOSDAQ:023160) Shares?

Jan 19
What Kind Of Shareholders Hold The Majority In Tae Kwang Corporation's (KOSDAQ:023160) Shares?

Do These 3 Checks Before Buying Tae Kwang Corporation (KOSDAQ:023160) For Its Upcoming Dividend

Dec 24
Do These 3 Checks Before Buying Tae Kwang Corporation (KOSDAQ:023160) For Its Upcoming Dividend

Is It Too Late To Consider Buying Tae Kwang Corporation (KOSDAQ:023160)?

Dec 06
Is It Too Late To Consider Buying Tae Kwang Corporation (KOSDAQ:023160)?

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: A023160's short term assets (₩297.1B) exceed its short term liabilities (₩33.0B).

Uzun Vadeli Yükümlülükler: A023160's short term assets (₩297.1B) exceed its long term liabilities (₩18.9B).


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: A023160 is debt free.

Borcun Azaltılması: A023160 had no debt 5 years ago.

Borç Kapsamı: A023160 has no debt, therefore it does not need to be covered by operating cash flow.

Faiz Kapsamı: A023160 has no debt, therefore coverage of interest payments is not a concern.


Bilanço


Sağlıklı şirketleri keşfedin